Category: News & Articles
... works for now
Nivolumab and pembrolizumab are checkpoint immunotherapy antibodies. They work by blocking barriers (or “checkpoints”) ... is with melanoma, which has long been known to respond to immunotherapy. In Australia, single or combination checkpoint immunotherapy substantially helps about half of people with melanoma , and ...
Category: Research
... is requested to attend the Inaugural International Cancer Immunotherapy Conference, September 16 -19, 2015, in New York, New York, USA. ... by the Cancer Research Institute, Association for Cancer Immunotherapy, European Academy of Tumor Immunology and American Association ... will bring together leaders in the fields of immunology and immunotherapy to disseminate and discuss recent research discoveries to ...
Category: General
Cancer immunotherapy is a therapeutic strategy that harnesses cancer patients own ... cells. A new class of newly developed drugs in cancer immunotherapy (called immune checkpoint inhibitors) can cause long lasting ... of important aspects of gene regulation involving immunotherapy checkpoint inhibitors. This project will increase our ...
Category: Research
... survival signalling pathways to sensitize melanoma to immunotherapy". Her research has drawn extensive attention from researchers in ... and internationally.
Research
Combining immunotherapy and targeted therapy in the treatment of human melanoma (Cancer ...
Category: Researcher Profiles
... of melanoma...
Oncolytic virotherapy, viral therapies, immunotherapy, melanoma, bladder cancer, breast cancer, lung cancer, prostate ...
Category: General
... National Science Week Cancer Public Seminar will explore immunotherapy and the future of cancer treatment.
National Science Week Public Seminar: Immunotherapy and other drugs: A future of cancer treatment
What does the ... National Science Week Cancer Public Seminar will explore immunotherapy and the future of cancer treatment
Cancer Public Seminar | ...
Category: General
... cancers all respond exceptionally well to new drugs called immunotherapy that ‘take the breaks off’ the immune system and let it kill ... predict that the same patients will go on to respond well to immunotherapy.
The HMRI Solution: HMRI researcher Dr Nikola Bowden is in the unique position of understanding the science of melanoma immunotherapy as well as ovarian drug therapy. She has a 5 year plan to ...
Category: General
... beyond the original site. A new treatment approach called immunotherapy can cause long-lasting melanoma regression. However, only a small proportion of melanoma patients benefit from immunotherapy. Resistance of melanoma to these treatments is closely related ... melanoma cells from death induced by targeted therapy and immunotherapy drugs. Understanding how theses cells evade death will improve ...
Category: News & Articles
... researchers have recently made progress in optimising immunotherapy, also called peanut “desensitisation”. In this process small ... with 28 children in Durham, North Carolina, showed that oral immunotherapy could reduce allergic reactions to peanut.
This study was ... Melbourne, studied an oral probiotic peanut combination immunotherapy in 62 allergic children without previous anaphylaxis. Children ...
Category: Researcher Profiles
... with metastatic melanoma respond to the new treatment, immunotherapy, and why others do not
Understanding the process where the ... in metastatic melanoma patients who have relapsed on immunotherapy. She will examine the pharmacokinetics of anti-PD-1 therapy in ... Research
Society for Melanoma Research
Society for Immunotherapy of Cancer
Hunter Melanoma Foundation
...
